Clinical study with cancer vaccine combined with Anti-PD1 (Pembrolizumab) in malignant lymphoma

Update Il y a 4 ans
Reference: EUCTR2015-003169-28

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The main objectives of the trial is to induce systemic immune responses against the lymphoma and correlated clinical responses, and additionally study feasibility and safety


Inclusion criteria

  • Follicular non-Hodgkin`s lymphoma stage III/IV, untreated or relapsed

Links